CoChat

Prostaglandin E2 Inhibits Fibroblast to Myofibroblast Transition via E. Prostanoid Receptor 2 Signaling and Cyclic Adenosine Monophosphate Elevation

Kolodsick, Jill E., Peters-Golden, Marc, Larios, José, Toews, Galen B., Thannickal, Victor J., Moore, Bethany B. · 2003 · American Journal of Respiratory Cell and Molecular Biology

The DOI matches its Crossref record, with a small difference in title or year; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Myofibroblasts, the hallmark of fibrotic disease, contribute to the pathology of fibrosis by secreting large amounts of extracellular matrix and contributing to alveolar contraction. Myofibroblasts are characterized by the expression of α-smooth muscle actin (α-SMA), a contractile protein normally associated with smooth muscle cells. Transforming growth factor-β1 (TGF-β1) is a well characterized profibrotic cytokine that induces myofibroblast transformation both in vitro and in vivo. We report here that the lipid mediator prostaglandin E2 (PGE2) inhibits TGF-β1–induced expression of α-SMA in primary fetal and adult lung fibroblasts. This inhibition of α-SMA expression is associated with a reduction in the expression of collagen I. Inhibitory actions of PGE2 are mediated via E prostanoid receptor 2 (EP2) signaling, but not by EP3 signaling, and increases in cyclic adenosine monophosphate production. The inhibitory effects of PGE2 on TGF-β1–induced α-SMA expression are mimicked by an EP2 selective agonist, butaprost, and by forskolin-induced direct activation of adenyl cyclase. An EP2 antagonist blocks the inhibitory effects of PGE2, and an EP3 agonist does not inhibit TGF-β1–mediated increases in α-SMA expression. Our results demonstrate that PGE2 inhibits transition of fibroblasts to myofibroblasts by an EP2 receptor-activated pathway. Augmenting this pathway may serve as a potent antifibrotic therapeutic strategy.

Overview

Integrity signals

Registry

Crossref · 10.1165/rcmb.2002-0243oc

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 13

  1. 2001, Chest, 120(1 Suppl), 77S
  2. 1981, Am. J. Pathol., 102, 427
  3. 1989, Lab. Invest., 60, 643
  4. 1996, Am. J. Pathol., 148, 527
  5. 1995, Exp. Nephrol., 3, 134
  6. 1994, Am. J. Pathol., 145, 114
  7. 1995, Am. J. Pathol., 147, 352
  8. 1996, Kidney Int. Suppl., 54, S46
  9. 1985, Am. Rev. Respir. Dis., 131, 94
  10. 1998, J. Cell. Biochem., 71, 254, 10.1002/(SICI)1097-4644(19981101)71:2<254::AID-JCB10>3.0.CO;2-L · doi:10.1002/(sici)1097-4644(19981101)71:2<254::aid-jcb10>3.0.co;2-l
  11. 1993, Am. J. Pathol., 143, 1754
  12. 1992, Lab. Invest., 67, 716
  13. 1995, J. Rheumatol., 22, 1876

Cited by

See all 297

Metadata

Authors
Kolodsick, J. E., Peters-Golden, M., Larios, J., Toews, G. B., Thannickal, V. J., & Moore, B. B.
Affiliations
  • University of Michigan (US)
  • Department of Internal Medicine, Pulmonary and Critical Care Medicine Division, University of Michigan School of Medicine, Ann Arbor, Michigan
Corresponding author
Moore, Bethany B.
Venue
American Journal of Respiratory Cell and Molecular Biology
Published
2003-11-01
Volume
29
Issue
5
Pages
537-544
ISSN
  • 1044-1549 (ISSN-L)
  • 1535-4989
OpenAlex
W1995721099
Cited by
294
References
37
Citations by year
2026: 7 · 2025: 7 · 2024: 10 · 2023: 12 · 2022: 8 · 2021: 7 · 2020: 11 · 2019: 15 · 2018: 16 · 2017: 11 · 2016: 10 · 2015: 15 · 2014: 19 · 2013: 16 · 2012: 15
FWCI
9.00
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory Cell and Molecular Biology (publishedVersion, public-domain)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r29ca079046-03)
  • National Heart, Lung, and Blood Institute (P50HL56402, HL071586, P50HL056402, P50HL60289, 2T32HL07749, R01HL071586, P50HL060289, T32HL007749)
  • National Cancer Institute (CA79046)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords
prostaglandin E2, myofibroblast differentiation, cyclic AMP, TGF-β1, alpha-smooth muscle actin, type I collagen, pulmonary fibrosis, antifibrotic therapy, butaprost, adenylate cyclase
MeSH terms
Cyclic AMP, Cell Differentiation, Fibroblasts, Colforsin, Humans, Dinoprostone, Receptors, Prostaglandin E

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prostaglandin E2 Inhibits Fibroblast to Myofibroblast Transition via E. Prostanoid Receptor 2 Signaling and Cyclic Adenosine Monophosphate Elevation. https://app.cochat.ai/papers/10.1165/rcmb.2002-0243oc
The paper
Kolodsick, J. E., Peters-Golden, M., Larios, J., Toews, G. B., Thannickal, V. J., & Moore, B. B. (2003). Prostaglandin E2 Inhibits Fibroblast to Myofibroblast Transition via E. Prostanoid Receptor 2 Signaling and Cyclic Adenosine Monophosphate Elevation. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2002-0243oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.